Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen

被引:19
|
作者
Lee, YS [1 ]
Wan, J [1 ]
Kim, BJ [1 ]
Bae, MA [1 ]
Song, BJ [1 ]
机构
[1] NIAAA, Lab Membrane Biochem & Biophys, Bethesda, MD 20892 USA
来源
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2006年 / 317卷 / 01期
关键词
D O I
10.1124/jpet.105.096719
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We previously reported that acetaminophen (APAP, 4-hydroxyacetanilide) caused apoptosis of C6 glioma cells. Therefore, we hypothesized that the level of p53, which usually stimulates apoptosis, might be increased after APAP exposure. However, APAP exposure for 24 h markedly decreased the p53 content and its downstream target p21 in a concentration-dependent manner. Reduction of p53 was not accompanied by a decrease in p53 mRNA in C6 glioma cells, suggesting that p53 was mainly affected at the protein level. Unexpectedly, APAP stimulated phosphorylation of p53 at Ser15, Ser20, and Ser37, which usually elevates p53 content. However, phosphorylation of these residues did not prevent APAP-induced decrease in p53. The p53 reduction was independent from the level of phospho-Akt, which is known to promote p53 degradation. Immunoblot analysis of the immunoprecipitated p53 revealed that increased amounts of murine double minute 2 (mdm2) and ubiquitin were bound to p53 during its degradation. Lactacystin and N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal (MG132), inhibitors of proteasomal proteolysis, prevented the decrease, supporting the proteasomal degradation of p53 upon APAP exposure. Pretreatment with chlormethiazole, an inhibitor of ethanol- inducible CYP2E1, significantly lowered the CYP2E1 enzyme activity and the rate of APAP-induced cell death while it prevented the reduction of p53 and p21 in C6 glioma cells. A nontoxic analog of APAP, 3-hydroxyacetanilde, did not reduce p53 and p21 contents in C6 glioma cells and LLC-PK1 porcine kidney cells. Taken together, our results show that APAP or its reactive metabolite(s) can directly reduce the p53 content through mdm2-mediated ubiquitin conjugation, despite phosphorylation of p53 at its N terminus.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [31] Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast
    Henchoz, S
    Chi, Y
    Catarin, B
    Herskowitz, I
    Deshaies, RJ
    Peter, M
    GENES & DEVELOPMENT, 1997, 11 (22) : 3046 - 3060
  • [32] Ubiquitin-independent p53 proteasomal degradation
    Tsvetkov, P.
    Reuven, N.
    Shaul, Y.
    CELL DEATH AND DIFFERENTIATION, 2010, 17 (01): : 103 - 108
  • [33] Ubiquitin-dependent protein degradation at the yeast endoplasmic reticulum and nuclear envelope
    Zattas, Dimitrios
    Hochstrasser, Mark
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 50 (01) : 1 - 17
  • [34] The role of copper in ubiquitin-dependent protein degradation in Alzheimer's disease
    Greenough, M.
    Opazo, C.
    Bush, A.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 157 - 157
  • [35] Angiotensin II stimulates lipolysis and ubiquitin-dependent protein degradation in muscle
    Brink, M
    Mitch, WE
    Price, SR
    England, BK
    Bailey, JL
    Ding, XY
    Delafontaine, P
    CIRCULATION, 1996, 94 (08) : 377 - 377
  • [36] The long N-terminus of the human monocarboxylate transporter 8 is a target of ubiquitin-dependent proteasomal degradation which regulates protein expression and oligomerization capacity
    Zwanziger, Denise
    Schmidt, Mathias
    Fischer, Jana
    Kleinau, Gunnar
    Braun, Doreen
    Schweizer, Ulrich
    Moeller, Lars Christian
    Biebermann, Heike
    Fuehrer, Dagmar
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 434 (0C) : 278 - 287
  • [37] Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases
    Musti, AM
    Treier, M
    Bohmann, D
    SCIENCE, 1997, 275 (5298) : 400 - 402
  • [38] Conformation-dependent phosphorylation of p53
    Adler, V
    Pincus, MR
    Minamoto, T
    Fuchs, SY
    Bluth, MJ
    BrandtRauf, PW
    Friedman, FK
    Robinson, RC
    Chen, JM
    Wang, XW
    Harris, CC
    Ronai, Z
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1686 - 1691
  • [39] Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
    Hafsi, Hind
    Santos-Silva, Daniela
    Courtois-Cox, Stephanie
    Hainaut, Pierre
    BMC CANCER, 2013, 13
  • [40] Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
    Hind Hafsi
    Daniela Santos-Silva
    Stéphanie Courtois-Cox
    Pierre Hainaut
    BMC Cancer, 13